Affordable Access

Escitalopram for comorbid depression and anxiety in elderly patients: A 12-week, open-label, flexible-dose, pilot trial.

Authors
Type
Published Article
Journal
The American journal of geriatric pharmacotherapy
Publication Date
Volume
4
Issue
3
Pages
201–209
Identifiers
PMID: 17062320
Source
Medline

Abstract

In this small study in elderly patients with comorbid MDD and GAD, treatment with escitalopram 10 to 20 mg/d for 12 weeks was associated with significant improvements in symptoms of depression and anxiety.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments
F